Source: (22) Enhancing Perinatal Mental Health Care with the MumMoodBooster Clinician Portal | LinkedIn
MumMoodBooster and Mum2BMoodBooster are evidence-based e-treatments designed to help women anywhere in Australia who are experiencing mild to moderately-severe antenatal or postnatal depression. Consisting of six interactive sessions, these programs are designed to help women develop skills and strategies that will assist in improving their mood.
These programs are offered free by the Perinatal Depression e-Consortium*, led by the Parent-Infant Research Institute, with optional weekly phone coach for mums with more severe symptoms.
Our treatment programs are based on best practice psychological treatment. Our latest research shows that MumMoodBooster is as effective as face-to-face cognitive-behavioral therapy for treating clinically diagnosed depression. Check out the evidence for MumMoodBooster here and here.
The Mum2BMoodBooster Clinician Portal
We are pleased to announce the release of the Mum2BMoodBooster Clinician Portal, which was developed with GPs, for health professionals, to allow direct referral and monitoring of patients as they use Mum2BMoodBooster.
In addition to the Mum2BMoodBooster Clinician Portal, PDeC also offers a widely used Clinician Portal to support their postnatal depression and anxiety treatment program, MumMoodBooster.
Key features of the Clinician Portal
- Seamless Referrals: Effortlessly refer expectant or new mothers experiencing perinatal depression or anxiety to the appropriate MumMoodBooster or Mum2BMoodBooster program.
- Evidence-Based Treatment: Facilitate access to effective evidence-based online CBT programs for mild to moderately severe depression, either as stand-alone treatments or as adjunctive therapies.
- Flexible Engagement: Choose the level of involvement and monitoring that best suits your patient’s needs and preferences.
- Personalised Monitoring: Conveniently monitor your patients’ mood symptoms and progress throughout their treatment journeys.
- Additional Screening: Whilst you may have already screened a patient, the online treatment programs offer additional EPDS screening assessment, PHQ-9 Patient Health Questionnaire, and the DSM-5 Cross-sectional symptom measure.
- Risk Alert Notifications: Patients receive timely email alerts whenever they exhibit concerning symptoms, such as suicidal ideation or escalating depression, advising them to speak to a health professional or contact a telephone support service.
Gain in-depth knowledge of the MumMoodBooster treatment programs and the Clinician Portal with our MumMoodBooster Program Guide and Clinician Portal Referral Guide.
Register once here for immediate, secure access to receive a unique referral code for all your patients to access the Mum2BMoodBooster program. For more information, contact piri@austin.org.au
The Perinatal Depression e-Consortium (PDeC) is led by the Parent-Infant Research Institute (PIRI) and funded by the Australian Department of Health, and includes Perinatal Anxiety & Depression Australia (PANDA), Monash University, Queensland University of Technology and Jean Hailes for Women’s Health.
Categories: News